Clinical Trial: Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device PROCTOeze(R) PLUS in the Relief of Haemorrhoidal Disease and Anal Irritation Symptoms

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944951) titled 'Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device PROCTOeze(R) PLUS in the Relief of Haemorrhoidal Disease and Anal Irritation Symptoms' on April 18.

Brief Summary: This trial aims to evaluate the overall performance and safety of the MD PROCTOeze(R) PLUS in relieving symptomatology of haemorrhoidal disease and anal irritation in adult patients affected by Grade I-II (Goligher classification) haemorrhoids as assessed by the patient and the Investigator at the end of the treatment period.

Study Start Date: Nov. 05, 2024

Study Type: INTERVENTIONAL

Condition: Haemorrhoidal Disease...